MEDICIBIO Trademark

Trademark Overview


On Thursday, December 2, 2021, a trademark application was filed for MEDICIBIO with the United States Patent and Trademark Office. The USPTO has given the MEDICIBIO trademark a serial number of 97153921. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by MediciBIO Co., LTD. The MEDICIBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medicine research, namely, clinical research in the field of medicine against genetic and rare diseases; Medical research in the field of medicines; Providing information on the testing, inspection, and research of medical products; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Development of pharmaceutical preparations and medicine; Pharmaceutical research and development; Medical research; Technical consultancy in relation to research services relating to foods and dietary supplements; Research and development of technology for medicinal chemical manufacturing
medicibio

General Information


Serial Number97153921
Word MarkMEDICIBIO
Filing DateThursday, December 2, 2021
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7273494
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements


Goods and ServicesMedicine research, namely, clinical research in the field of medicine against genetic and rare diseases; Medical research in the field of medicines; Providing information on the testing, inspection, and research of medical products; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Development of pharmaceutical preparations and medicine; Pharmaceutical research and development; Medical research; Technical consultancy in relation to research services relating to foods and dietary supplements; Research and development of technology for medicinal chemical manufacturing

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMediciBIO Co., LTD
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 17095
KR

Party NameMediciBIO Co., LTD
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGyeonggi-do 17095
KR

Party NameMediciBIO Co., LTD
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 17095
KR

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 30, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 13, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 13, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 13, 2023SUSPENSION LETTER WRITTEN
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 12, 2022NON-FINAL ACTION E-MAILED
Monday, September 12, 2022NON-FINAL ACTION WRITTEN
Monday, September 12, 2022ASSIGNED TO EXAMINER
Tuesday, December 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 6, 2021NEW APPLICATION ENTERED